Skip to main content
. 2016 Mar 2;15:137. doi: 10.1186/s12936-016-1173-1

Fig. 1.

Fig. 1

Ex vivo drug susceptibility (median IC50s) of standard anti-malarials in Plasmodium falciparum (closed symbols) and Plasmodium vivax (open symbols) clinical field isolates. IC50 estimates depicted in the Figure were derived by using NONMEM